Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain
Austen Bernardi, Yihan Huang, Bradley Harris, et al.
PLoS ONE (2020) Vol. 15, Iss. 8, pp. e0237295-e0237295
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
Qi Yang, Thomas A. Hughes, Anju Kelkar, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 213
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
Nunzia D’Onofrio, Lucia Scisciola, Celestino Sardu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 93
Contributions of the international plant science community to the fight against human infectious diseases – part 1: epidemic and pandemic diseases
Maria Lobato‐Gómez, Xin Huang, Derry Alvarez, et al.
Plant Biotechnology Journal (2021) Vol. 19, Iss. 10, pp. 1901-1920
Open Access | Times Cited: 59
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 58
The Emergency Response Capacity of Plant-Based Biopharmaceutical Manufacturing-What It Is and What It Could Be
Daniel Tusé, Somen Nandi, Karen A. McDonald, et al.
Frontiers in Plant Science (2020) Vol. 11
Open Access | Times Cited: 67
Impact of Expressing Cells on Glycosylation and Glycan of the SARS-CoV-2 Spike Glycoprotein
Yan Wang, Zhenhua Wu, Wenhua Hu, et al.
ACS Omega (2021) Vol. 6, Iss. 24, pp. 15988-15999
Open Access | Times Cited: 42
Inhibition of Protein N- Glycosylation Blocks SARS-CoV-2 Infection
Aitor Casas-Sánchez, Alessandra Romero-Ramirez, E. R. Hargreaves, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 38
Comparative Immunogenicity of the Recombinant Receptor-Binding Domain of Protein S SARS-CoV-2 Obtained in Prokaryotic and Mammalian Expression Systems
Iuliia A. Merkuleva, Д. Н. Щербаков, M. B. Borgoyakova, et al.
Vaccines (2022) Vol. 10, Iss. 1, pp. 96-96
Open Access | Times Cited: 35
Quantitative profiling of N-glycosylation of SARS-CoV-2 spike protein variants
Yongjing Xie, Michael Butler
Glycobiology (2023) Vol. 33, Iss. 3, pp. 188-202
Open Access | Times Cited: 18
Current updates and research on plant-based vaccines for coronavirus disease 2019
Asqwin Uthaya Kumar, Kirthikah Kadiresen, Wen Cong Gan, et al.
Clinical and Experimental Vaccine Research (2021) Vol. 10, Iss. 1, pp. 13-13
Open Access | Times Cited: 34
Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19
Corbin England, Jonathan TrejoMartinez, Paula PerezSanchez, et al.
Life (2023) Vol. 13, Iss. 3, pp. 617-617
Open Access | Times Cited: 15
Antigenic Cross-Reactivity Between SARS-CoV-2 S1-RBD and Its Receptor ACE2
Yen‐Chung Lai, Yuwei Cheng, Chiao-Hsuan Chao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 21
Using molecular dynamics simulations to interrogate T cell receptor non-equilibrium kinetics
Zachary A. Rollins, Roland Faller, Steven C. George
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2124-2133
Open Access | Times Cited: 20
SARS-CoV-2 spike binding to ACE2 is stronger and longer ranged due to glycan interaction
Yihan Huang, Bradley Harris, Shiaki A. Minami, et al.
Biophysical Journal (2021) Vol. 121, Iss. 1, pp. 79-90
Open Access | Times Cited: 27
ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern
Tsung-I Tsai, Jahan S. Khalili, Mark Gilchrist, et al.
Antiviral Research (2022) Vol. 199, pp. 105271-105271
Open Access | Times Cited: 18
Effect of Hyperglycemia on COVID-19 Outcomes: Vaccination Efficacy, Disease Severity, and Molecular Mechanisms
Celestino Sardu, Raffaele Marfella, Francesco Prattichizzo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 6, pp. 1564-1564
Open Access | Times Cited: 17
Herbal medications and natural products for patients with covid-19 and diabetes mellitus: Potentials and challenges
Abdurrahman Pharmacy Yusuf, Jianye Zhang, Jingquan Li, et al.
Phytomedicine Plus (2022) Vol. 2, Iss. 3, pp. 100280-100280
Open Access | Times Cited: 17
Engineering a “muco‐trapping” ACE2‐immunoglobulin hybrid with picomolar affinity as an inhaled, pan‐variant immunotherapy for COVID‐19
Karthik Tiruthani, Carlos Cruz‐Teran, Jasper Fuk‐Woo Chan, et al.
Bioengineering & Translational Medicine (2024) Vol. 9, Iss. 4
Open Access | Times Cited: 3
Picomolar inhibition of SARS-CoV-2 variants of concern by an engineered ACE2-IgG4-Fc fusion protein
Hristo L. Svilenov, Julia Sacherl, A. Reiter, et al.
Antiviral Research (2021) Vol. 196, pp. 105197-105197
Open Access | Times Cited: 18
Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection
José R. Vargas-Rodríguez, Idalia Garza‐Veloz, Virginia Flores‐Morales, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 11
Entropic contribution of ACE2 glycans to RBD binding
Mauro L. Mugnai, Sucheol Shin, D. Thirumalai
Biophysical Journal (2023) Vol. 122, Iss. 12, pp. 2506-2517
Open Access | Times Cited: 6
Allosteric communication between ACE2 active site and binding interface with SARS-CoV-2
Mauro L. Mugnai, D. Thirumalai
The Journal of Chemical Physics (2023) Vol. 158, Iss. 21
Closed Access | Times Cited: 6
Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition
Lorenzo Di Rienzo, Michele Monti, Edoardo Milanetti, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3006-3014
Open Access | Times Cited: 14
Biomolecular interactions with nanoparticles: applications for coronavirus disease 2019
Mohammed A. H. Farouq, Mohammed M. Al Qaraghuli, Karina Kubiak-Ossowska, et al.
Current Opinion in Colloid & Interface Science (2021) Vol. 54, pp. 101461-101461
Open Access | Times Cited: 11
Curious Binding Energy Increase between the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein and Angiotensin-Converting Enzyme 2 Adsorbed on a Silane Monolayer from Molecular Dynamics Simulations
Solène Lecot, Yann Chevolot, Magali Phaner-Goutorbe, et al.
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 39, pp. 11078-11090
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top